USPTO serial 79018967
ALBUDAB
Reviewed by CopyMark Law Group
Reg. 3318431Status 404
- Filing date
- Status date
- Registration date
- Oct 23, 2007
- Examiner
- STOIDES, KATHERINE
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALBUDAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cambridge CB4 0WG, GB
Cambridge CB4 0WG, GB
Cambridge CB4 0WG, GB
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | BIOLOGICAL PRODUCTS, NAMELY, HALF-LIFE EXTENDED PRODUCTS, NAMELY ANTIBODIES, ANTIBODY FRAGMENTS, PROTEINS, CHIMERIC PROTEINS, DRUG CONJUGATES AND ENZYMES, FOR USE IN RESEARCH AND DEVELOPMENT OF PHARMACEUTICALS AND FOR MANUFACTURE OF PHARMACEUTICALS | SECTION 71 - CANCELLED | — |
| 005 | BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES; BIOLOGICAL PRODUCTS, NAMELY, A DRUG DELIVERY SYSTEM COMPRISING ANTIBODIES OR ANTIBODY FRAGMENTS WHICH EXTEND THE EFFECT OF A WIDE VARIETY OF THERAPEUTIC AGENTS, FOR MEDICAL USE AND FOR USE IN MEDICAL TREATMENT; BIOLOGICAL PRODUCTS, NAMELY, ALLERGY MEDICATIONS, PAIN MEDICATION, ACNE MEDICATION, ADRENAL HORMONE PREPARATIONS, ANALGESICS, ANAESTHETICS FOR SURGICAL AND NON-SURGICAL USE, ANTACIDS, ANTIARRHYTHMLCS, ANTIBACTERIAL PHARMACEUTICALS, ANTIBIOTICS, ANTICOAGULANTS, ANTICONVULSANTS, ANTIDEPRESSANTS, ANTIDIABETIC PREPARATIONS, ANTIEMETICS, ANTIHISTAMINES,ANTIHYPERTENSIVES, ANTIPARASITICS, ANTISEPTICS, ANTITOXIC SERA, ANTIVIRALS, ANTI-ARTHRITIC COMPOSITIONS AND PREPARATIONS, ANTI-CANCER PREPARATIONS, ANTI-COUGH PREPARATIONS, ANTI-DERMOINFECTIVES, ANTI-DIABETIC PHARMACEUTICALS, ANTI-INFECTIVES, ANTI-INFLAMMATORIES, ANTI-SARCOMA PREPARATIONS, ANTI-VENIN, ASPIRIN PREPARATIONS , ANTI- BACTERIAL AND BACTERIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES, BETA BLOCKERS, BRONCHIAL DILATORS, BURN RELIEF MEDICATION, CARDIOVASCULAR PHARMACEUTICALS, CENTRAL NERVOUS SYSTEM STIMULANTS, CHEMOTHERAPEUTICS, CHLORAMPHENICOL PREPARATIONS, CHOLESTEROL REDUCERS, CHONDROITIN PREPARATIONS, COLD SORE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, CONTRACEPTIVE PREPARATIONS, COUGH TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, DECONGESTANTS, DERMATOLOGICAL PHARMACEUTICAL PRODUCTS, DIAPHORETICS, DIETARY SUPPLEMENTS, DIURETICS, DRUG DELIVERY AGENTS CONSISTING OF COMPOUNDS THAT FACILITATE DELIVERY OF A WIDE RANGE OF PHARMACEUTICALS, EMETICS, EMMENAGOGUES,ERYTIIROMYCIN PREPARATIONS, FERTILITY ENHANCEMENT PREPARATIONS,FOOD SUPPLEMENTS, GASTRO-INTESTINAL TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, GERMICIDES, GLAUCOMA AGENTS, HAIR GROWTH STIMULANTS, HEADACHE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, HAEMORRHOID TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, HORMONE PREPARATIONS, HYDROCORTISONE PREPARATIONS, HYPNOTICS, PHARMACEUTICALS FOR TREATMENT AND/OR PROPHYLAXIS OF ANAPHYLACTIC REACTIONS, INSULIN PREPARATIONS, LACTAGOGUES, MEDICAL DIAGNOSTIC REAGENTS, MEDICATED MOUTH CARE AND TREATMENT PREPARATIONS, MEDICATED SKIN HAIR PREPARATIONS, MEDICATED HAIR CARE PREPARATIONS, MIGRAINE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, MIXED ANTIBIOTIC PREPARATIONS, MIXED VITAMIN; PREPARATIONS, MOTION SICKNESS TREATMENT PREPARATIONS, MUSCLE RELAXANTS, NAIL FUNGUS TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, NASAL SPRAY PREPARATIONS, NAUSEA TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, OPHTHALMIC PREPARATIONS, OPHTHALMOLOGIC PREPARATIONS, PAIN RELIEF MEDICATION, PANCREAS HORMONE PREPARATIONS, ORAL CONTRACEPTIVES, PARASITICIDES FOR MEDICAL USE, PENICILLIN PREPARATIONS, PHARMACEUTICAL ANTITUSSIVE-COLD PREPARATIONS, PHARMACEUTICAL ANTI-ALLERGIC PREPARATIONS AND SUBSTANCES, PHARMACEUTICALS FOR THE TREATMENT OF ERECTILE DYSFUNCTION, ANTICOAGULANTS, ANTIDEPRESSANTS, APPETITE SUPPRESSANTS, ANTI-OBESITY PREPARATIONS, PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF GOUT, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF HEART RHYTHM DISORDERS, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF INFECTIOUS DISEASES, PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM, PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT AND/OR PROPHYLAXIS OF GASTRO-INTESTINAL DISEASES, PHARMACEUTICAL PREPARATIONS FOR INHALATION FOR THE TREATMENT AND/OR PROPHYLAXIS OF PULMONARY HYPERTENSION, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF CHRONIC PULMONARY DISEASE, PHARMACEUTICAL PREPARATIONS FOR OCULAR OR INTRAOCULAR SURGERY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF HORMONAL DISORDERS AND THE PREVENTION OF OSTEOPOROSIS, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF ALLERGIC RHINITIS AND ASTHMA, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF DIABETES, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF SKIN DISORDERS, PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY, PHARMACEUTICAL PREPARATIONS FOR WOUNDS, PHARMACEUTICAL PREPARATIONS FOR USE IN UROLOGY, BLOOD CLOTTING AID AND DELIVERY SYSTEMS FOR USE IN HUMAN MEDICINE, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/ORPROPHYLAXIS OF EYE DISEASES AND CONDITIONS, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR CHLOASMA, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR PREVENTING SKIN BLEMISHES DURING PREGNANCY, PHARMACEUTICAL PRODUCTS FOR OPHTHALMOLOGICAL USE, PHARMACEUTICAL PRODUCTS FOR THE TREATMENT AND/OR PROPHYLAXIS OF BONE DISEASES, PHARMACEUTICAL PRODUCTS FOR THE TREATMENT AND/OR PROPHYLAXIS OF VIRAL AND INFECTIOUS DISEASES, FOR THE TREATMENT AND/OR PROPHYLAXIS OF CANCER, PHARMACEUTICAL PRODUCTS FOR TREATING AND/OR PROPHYLAXIS OF RESPIRATORY DISEASES AND ASTHMA, LIPID LOWERING AGENTS, PSYCHOTROPIC'S, PITUITARY HORMONE PREPARATIONS, PREPARATIONS FOR THE SUPPRESSION OF HORMONES, PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF COLDS,RADIATION SICKNESS TREATING AGENTS, SEDATIVES, STEROIDS, MEDICATIONS FOR USE IN WEIGHT REDUCTION PROGRAMMES, STREPTOMYCIN PREPARATIONS, SYNTHETIC NARCOTICS, SYNTHETIC PEPTIDES FOR PHARMACEUTICAL PURPOSES, TETRACYCLINE PREPARATIONS, THIOLUTIN PREPARATIONS, THREONINE PREPARATIONS, TRANQUILISERS, TUMOUR SUPPRESSING AGENTS, VACCINES, PAIN RELIEF MEDICATION, ALL CONTAINING ANTIBODIES OR ANTIBODY FRAGMENTS FOR MEDICAL USE AND FOR USE IN MEDICAL TREATMENT; MEDICAL PREPARATIONS, NAMELY ANTIBODIES, ANTIBODY FRAGMENTS, PROTEINS, CHIMERIC PROTEINS AND ENZYMES FOR TREATMENT OF PAIN, CENTRAL NERVOUS SYSTEM, INFLAMMATORY, RESPIRATORY, NEOPLASTIC, AUTOIMMUNE, INFECTION, NEUROLOGICAL, CARDIOVASCULAR, AND GASTROINTESTINAL DISEASES AND CONDITIONS, AND CANCER | SECTION 71 - CANCELLED | — |
| 042 | RESEARCH AND DEVELOPMENT SERVICES PERFORMED FOR OTHERS IN THE FIELDS OF DRUG DISCOVERY, DRUG DISCOVERY PRODUCTS, PHARMACEUTICALS, MEDICINAL DIAGNOSTICS, AND BIOLOGICAL PRODUCTS; PHARMACEUTICAL AND BIOLOGICAL PRODUCT DEVELOPMENT CONSULTATION; BIOTECHNICAL RESEARCH, CONSULTANCY AND TESTING; LABORATORY RESEARCH AND DEVELOPMENT SERVICES RELATING TO THE PRODUCTION OF ANTIBODIES | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Domantis Limited
- Other trademarks owned by Domantis Limited
- Other trademarks owned by Domantis Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ALBUDAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 20, 2016 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Feb 20, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 10, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 13, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 13, 2015 | INPC | INVALIDATION PROCESSED | — |
| Jan 30, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 30, 2014 | C71T | CANCELLED SECTION 71 | — |
| Jun 4, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 22, 2009 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 29, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 29, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 25, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 12, 2007 | PLGL | ASSIGNED TO PARALEGAL | — |
| Nov 2, 2007 | AMD7 | SEC 7 REQUEST FILED | — |
| Nov 2, 2007 | PAPER RECEIVED | — | |
| Oct 23, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 16, 2007 | FAXX | FAX RECEIVED | — |
| Aug 7, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 18, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 22, 2007 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 7, 2007 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 7, 2007 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 16, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 15, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 26, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 20, 2007 | ALIE | ASSIGNED TO LIE | — |
| Mar 19, 2007 | PAPER RECEIVED | — | |
| Nov 20, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2006 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 15, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 1, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 16, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 16, 2006 | PAPER RECEIVED | — | |
| Jun 10, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 9, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 16, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 16, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 16, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 15, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 6, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Jan 5, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |